How MDMA boosts pleasure and social connection
Official title: MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach
Funded at Mclean Hospital · NIH-11307600 · Data updated 2026-11-12
Researchers are testing how MDMA and its active parts increase pleasure and social connection to help people with PTSD or depression who struggle with loss of interest.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mclean Hospital NIH-funded |
| Lab location | 1 site (Belmont, United States) |
| Project start | April 1, 2025 |
| Project end | March 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $2,876,123 |
| NIH project number | 4RF1MH136052-02 |
| Project ID | NIH-11307600 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is most relevant to adults with PTSD or treatment-resistant depression who experience anhedonia and might be candidates for future MDMA-related therapies.
✕Less likely to help
People without loss of pleasure, children, pregnant people, or those with active substance-use disorders may not directly benefit from these findings.
What this research studies
This project uses a reverse-translational approach that begins in animals to model human reward learning. In rats, researchers run touchscreen-based reward learning tasks while recording brain activity to find what parts of MDMA drive pro-pleasure effects. They compare stereoselective components and metabolites and study serotonin-related systems linked to anhedonia. The goal is to separate the drug’s helpful effects from unwanted outcomes like neurotoxicity and abuse potential.
Why it matters
Potential benefit: If successful, this work could lead to safer MDMA-derived treatments that reduce anhedonia in PTSD and depression with fewer side effects.
How similar studies have gone: Clinical trials have shown promising benefits of MDMA-assisted therapy for PTSD and depression, but this animal-based touchscreen and brain-recording approach to pinpoint mechanisms is novel.
Where this research is happening
-
Mclean Hospital
Belmont, United States Active
Researchers
- Principal investigator: Kangas, Brian D. — Mclean Hospital
- Study coordinator: Kangas, Brian D.
Related research
Other NIH-funded projects on the same topics.
-
Neurobiological signs of resilience and recovery from substance abuse in youth who faced childhood adversity
A long-term study will explore brain patterns in young people who faced childhood adversity to understand why some stay resilient and avoid substance problems.
-
APOE, fats, and immune responses in human brain cells
This project looks at how different APOE genes change the way brain cells handle fats and inflammation for people affected by Alzheimer’s, Parkinson’s, and Lewy body dementia.
-
Decoding Dysmenorrhea: Longitudinal Pain Phenotypes in Adolescents and Young Adults
A study on how menstrual pain develops over time in teenagers and young adults, exploring brain and behavior to understand why some have ongoing pain.
-
BDNF's role in neuron-astrocyte signaling linked to schizophrenia risk
Researchers are exploring how brain-derived neurotrophic factor (BDNF) shapes the communication between neurons and support cells to understand schizophrenia risk.
-
Gut microbiome and multisensory sensitivity in teen menstrual pain
A study in adolescent girls with moderate-to-severe menstrual pain will explore how gut bacteria relate to their pain and sensitivity to different senses.
-
Scalable, quick digital help for new mothers with intrusive postpartum thoughts
A brief, self-guided digital session helps new parents understand and reduce distress from unwanted postpartum thoughts.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.